Second Sight Medical Products Inc, maker of the Argus II -- an artificial retina developed by biomedical engineering professor Mark Humayun -- made its initial public offering on November 19. With this "bionic eye," Humayun has helped restore vision to patients like Lisa Kulik.
Below is a sampling of recent of media articles about this milestone.
 |
Shares of Second Sight Medical Products Inc, a maker of artificial retinas designed to partially restore sight to the blind, more than doubled in their market debut. (View article) |
 |
Shares of Second Sight Medical Products Inc, a maker of artificial retinas designed to partially restore sight to the blind, more than doubled in their market debut. (View article) |
 |
Second Sight Medical Products, which sells camera-based retinal implants that restore partial vision to the blind, raised $32 million by offering 3.5 million shares at $9, as expected. Second Sight Medical Products plans to list on the NASDAQ under the symbol EYES. MDB Capital Group acted as the sole bookrunner on the deal. (View article) |
 |
Medical device company Second Sight Medical Products (NASDAQ:EYES) had to like the view of its initial public offering Wednesday. The company, which makes implantable visual prosthetics, raised $32 million in the IPO by offering 3.5 million shares at 9, as expected. The stock was near 21, up 133%, in afternoon trading on the stock market today. (View article) |
 |
Second Sight Medical Products, Inc. (Nasdaq: EYES) announced the pricing of its initial public offering of 3,500,000 shares of common stock, at a price of $9.00 per share. Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. (View article) |
